These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 18054882

  • 1. Effects of study methods and biases on estimates of invasive breast cancer overdetection with mammography screening: a systematic review.
    Biesheuvel C, Barratt A, Howard K, Houssami N, Irwig L.
    Lancet Oncol; 2007 Dec; 8(12):1129-1138. PubMed ID: 18054882
    [Abstract] [Full Text] [Related]

  • 2. Biases in estimates of overdetection due to mammography screening.
    Zahl PH, Jørgensen KJ, Maehlen J, Gøtzsche PC.
    Lancet Oncol; 2008 Mar; 9(3):199-201; author reply 201-2. PubMed ID: 18308246
    [No Abstract] [Full Text] [Related]

  • 3. Magnetic resonance imaging screening of the contralateral breast in women with newly diagnosed breast cancer: systematic review and meta-analysis of incremental cancer detection and impact on surgical management.
    Brennan ME, Houssami N, Lord S, Macaskill P, Irwig L, Dixon JM, Warren RM, Ciatto S.
    J Clin Oncol; 2009 Nov 20; 27(33):5640-9. PubMed ID: 19805685
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Early results of breast cancer screening research].
    Nowicki A, Stogowska I.
    Ginekol Pol; 2007 Jun 20; 78(6):464-70. PubMed ID: 17899703
    [Abstract] [Full Text] [Related]

  • 8. Lead times and overdetection due to prostate-specific antigen screening: estimates from the European Randomized Study of Screening for Prostate Cancer.
    Draisma G, Boer R, Otto SJ, van der Cruijsen IW, Damhuis RA, Schröder FH, de Koning HJ.
    J Natl Cancer Inst; 2003 Jun 18; 95(12):868-78. PubMed ID: 12813170
    [Abstract] [Full Text] [Related]

  • 9. Perceptions of overdetection of breast cancer among women 70 years of age and older in the USA: a mixed-methods analysis.
    Pappadis MR, Volk RJ, Krishnan S, Weller SC, Jaramillo E, Hoover DS, Giordano SH, Tan A, Sheffield KM, Housten AJ, Goodwin JS.
    BMJ Open; 2018 Jun 14; 8(6):e022138. PubMed ID: 29903800
    [Abstract] [Full Text] [Related]

  • 10.
    Melnikow J, Fenton JJ, Whitlock EP, Miglioretti DL, Weyrich MS, Thompson JH, Shah K.
    ; 2016 01 14. PubMed ID: 26866210
    [Abstract] [Full Text] [Related]

  • 11. Overdiagnosis in the population-based service screening programme with mammography for women aged 40 to 49 years in Sweden.
    Hellquist BN, Duffy SW, Nyström L, Jonsson H.
    J Med Screen; 2012 Mar 14; 19(1):14-9. PubMed ID: 22355181
    [Abstract] [Full Text] [Related]

  • 12. Changes in incidence of in situ and invasive breast cancer by histology type following mammography screening.
    Luke C, Priest K, Roder D.
    Asian Pac J Cancer Prev; 2006 Mar 14; 7(1):69-74. PubMed ID: 16629519
    [Abstract] [Full Text] [Related]

  • 13. Women's Acceptance of Overdetection in Breast Cancer Screening: Can We Assess Harm-Benefit Tradeoffs?
    Stiggelbout A, Copp T, Jacklyn G, Jansen J, Liefers GJ, McCaffery K, Hersch J.
    Med Decis Making; 2020 Jan 14; 40(1):42-51. PubMed ID: 31722605
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The National Breast and Cervical Cancer Early Detection Program: report on the first 4 years of mammography provided to medically underserved women.
    May DS, Lee NC, Nadel MR, Henson RM, Miller DS.
    AJR Am J Roentgenol; 1998 Jan 14; 170(1):97-104. PubMed ID: 9423608
    [Abstract] [Full Text] [Related]

  • 16. Overdiagnosis of invasive breast cancer due to mammography screening: results from the Norwegian screening program.
    Kalager M, Adami HO, Bretthauer M, Tamimi RM.
    Ann Intern Med; 2012 Apr 03; 156(7):491-9. PubMed ID: 22473436
    [Abstract] [Full Text] [Related]

  • 17. Modeling the impact of treatment and screening on U.S. breast cancer mortality: a Bayesian approach.
    Berry DA, Inoue L, Shen Y, Venier J, Cohen D, Bondy M, Theriault R, Munsell MF.
    J Natl Cancer Inst Monogr; 2006 Apr 03; (36):30-6. PubMed ID: 17032892
    [Abstract] [Full Text] [Related]

  • 18. Late-stage breast cancer among women with recent negative screening mammography: do clinical encounters offer opportunity for earlier detection?
    Mouchawar J, Taplin S, Ichikawa L, Barlow WE, Geiger AM, Weinmann S, Gilbert J, Manos MM, Ulcickas Yood M.
    J Natl Cancer Inst Monogr; 2005 Apr 03; (35):39-46. PubMed ID: 16287884
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Positive predictive value of screening mammography by age and family history of breast cancer.
    Kerlikowske K, Grady D, Barclay J, Sickles EA, Eaton A, Ernster V.
    JAMA; 1993 Nov 24; 270(20):2444-50. PubMed ID: 8230621
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.